Physician profile
Daniel J Cain
NPI 1518995323
$1,199.69
in general payments reported to CMS, 2019-2025
21 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2020: $101 · 2021: $84.86 · 2022: $198 · 2023: $86.80 · 2024: $160 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $375.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $335.71 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Organon LLC | $177.52 | 2023-2024 | Nexplanon |
| Minerva Surgical, INC | $165.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.98 | 2022 | |
| Mayne Pharma Commercial LLC | $53.46 | 2022-2023 | |
| Hologic Sales and Service, LLC | $52.95 | 2019-2021 | |
| Channel Medsystems, INC. | $44.49 | 2022 | |
| Roche Diagnostics Corporation | $39.97 | 2019 | |
| Coopersurgical, INC. | $35.71 | 2019-2025 | Sos |
| Optumhealth Care Solutions, LLC | $34.73 | 2023-2025 | Eitan Medical, Vivify Health Care Team Portal 001, Zyno Solutions |
| Aspira Women'S Health INC | $31.75 | 2022 | |
| Ethicon US, LLC | $28.55 | 2019 | |
| Exact Sciences Corporation | $19.79 | 2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $18.01 | 2019 | |
| Sage Therapeutics, LLC | $16.71 | 2025 | Zurzuvae |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $16.71 | 2025 | Qelbree |
| Sumitomo Pharma America, INC. | $16.07 | 2025 | Myfembree |
| Astellas Pharma US INC | $16.00 | 2025 | Veozah |
| Novartis Pharmaceuticals Corporation | $13.44 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.36 | 2022 | |
| Allergan, INC. | $11.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Cain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.